Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Astrid Ortiz

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 13, 2007
A long-acting selective neuropeptide Y2 receptor PEGylated peptide agonist reduces food intake in miceLynn B DeCarr, Thomas M Buckholz, Lucinda F Milardo, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Synthesis of water-soluble prodrugs of BMS-191011: a maxi-K channel opener targeted for post-stroke neuroprotectionPiyasena Hewawasam, Min Ding, Nathan Chen, et al.
American Journal of Clinical Pathology|September 22, 2010
A quality management systems approach for CD4 testing in resource-poor settingsLarry E Westerman, Luciana Kohatsu, Astrid Ortiz, et al.
Journal of Medicinal Chemistry|February 3, 2007
3-[(5-Chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl ]-1,3,4-oxadiazol-2(3H)-one, BMS-191011: opener of large-conductance Ca(2+)-activated potassium (maxi-K) channels, identification, solubility, and SARJeffrey L Romine, Scott W Martin, Nicholas A Meanwell, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Heterocyclic aminopyrrolidine derivatives as melatoninergic agentsLi-Qiang Sun, Jie Chen, Ronald J Mattson, et al.
Bioorganic & Medicinal Chemistry|May 16, 2006
Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonistsKevin W Gillman, Mendi A Higgins, Graham S Poindexter, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 AntagonistsShuanghua Hu, Yazhong Huang, Milind Deshpande, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|February 13, 2007
A long-acting selective neuropeptide Y2 receptor PEGylated peptide agonist reduces food intake in miceLynn B DeCarr, Thomas M Buckholz, Lucinda F Milardo, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Synthesis of water-soluble prodrugs of BMS-191011: a maxi-K channel opener targeted for post-stroke neuroprotectionPiyasena Hewawasam, Min Ding, Nathan Chen, et al.
American Journal of Clinical Pathology|September 22, 2010
A quality management systems approach for CD4 testing in resource-poor settingsLarry E Westerman, Luciana Kohatsu, Astrid Ortiz, et al.
Journal of Medicinal Chemistry|February 3, 2007
3-[(5-Chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl ]-1,3,4-oxadiazol-2(3H)-one, BMS-191011: opener of large-conductance Ca(2+)-activated potassium (maxi-K) channels, identification, solubility, and SARJeffrey L Romine, Scott W Martin, Nicholas A Meanwell, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Heterocyclic aminopyrrolidine derivatives as melatoninergic agentsLi-Qiang Sun, Jie Chen, Ronald J Mattson, et al.
Bioorganic & Medicinal Chemistry|May 16, 2006
Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonistsKevin W Gillman, Mendi A Higgins, Graham S Poindexter, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 AntagonistsShuanghua Hu, Yazhong Huang, Milind Deshpande, et al.
Pageof 1